In this article, I discuss recent developments in the field
look for its roots and ancestors. Those interested in synthetic biology often come to be interested in the discipline's genealogy, and both the present and the past of synthetic biology seem to be in need of being stabilized.
In the early twentieth century, Leduc's work resonated with then-current questions about the origins and properties of life; yet, its reception was mixed. It was varyingly judged interesting, spectacular, promising, unrealistic, and unserious (Keller 2002) . By today's standards, his arguments sound absurd (Keller 2002) , and Leduc is not often counted as a predecessor of contemporary synthetic biologists. His normative and philosophical conception of biology-best articulated in the second chapter of his book La Biologie Synthétique (1912) and in chapter 10 in his book The Mechanism of Life (1911) -does, however, resonate with current debates. Biology, Leduc argued, "must be successively descriptive, analytical, and synthetic" (Leduc 1911, p. 113) . What he called the synthetic method was designed for "reproduction by the forces of physics of biological phenomena that must contribute to give us a comprehension of life" (Leduc 1912, p. 12) .
A century after Leduc's books, a number of authors have offered various accounts of synthetic biology's disciplinary relationships. In an article in which he tried to "localize these new disciplines in the changing landscape of biological disciplines," one historian argued that synthetic biology represents the "last step in the project of early T he past 3 years have witnessed some important develop ments in the field of synthetic biology in France. Three official reports have been published, the Observatoire for Synthetic Biology has been set up, and several research groups have been created. (I use the French observatoire instead of its English equivalent throughout this article because of its typically more general meaning: an institution for observing, documenting, and monitoring the field.) Therefore, the time has come to look at the history and current state of synthetic biology in France.
The early history of synthetic biology in France
One Frenchman who has recently gained notoriety is Stéphane Leduc, author of La Biologie Synthétique, Étude de Biophysique (Leduc 1912) . It is common for contemporary academics, when they retrace the history of synthetic biology, to cite Leduc as being the first author to have coined the term synthetic biology (although his 1912 book is usually referenced, it must be noted that he had already devoted a whole chapter to synthetic biology in The Mechanism of Life [1911] ). Making reference to Leduc is, however, both problematic and interesting. It is problematic because Leduc used the term to talk about something other than what we understand today by the term synthetic biology-namely, inanimate things, such as crystals-but it is interesting because scientists' reflections about the current and future development of synthetic biology often bring them back to Biology in History molecular biologists to 'naturalize' the organic world" (Morange 2009, p. 51) . Others have highlighted some of the "striking similarities" between synthetic biology and synthetic chemistry (Bensaude-Vincent 2009) and have argued that the "history of synthetic chemistry offers a possible roadmap for the development and impact of synthetic biology" (Yeh and Wendell 2007, p. 521; yet, the latter also state that it is a "subdiscipline of bioengineering"). Others, still, write that the "field is in a situation similar to mechanical engineering in the early 1800s and microelectronics in the early 1950s" (Haseloff et al. 2009, p. 389) . There are, of course, other histories and complexities that one could mention (e.g., Campos 2010), but suffice it to say here that histo rical accounts varyingly retrace synthetic biology's roots and relationships to biology, chemistry, and engineering. This diversity is, of course, not a problem to be solved. There is, in fact, no single history of synthetic biology to be written, no single vantage point that can be favored. The emergence of synthetic biology is at once a development pushed by biologists who, during and after the Human Genome Project (1990 Project ( -2003 , started to join hands with physicists and computer scientists; an expansion of engineering principles into the realms of the life sciences; the institutionalization of a discipline through dedicated conferences, courses, journals, and research groups; and a cross-fertilization of bio logy, chemistry, engineering, and computer science. Since synthetic biology combines the tools, metaphors, visions, and methods of various disciplines, it should come as no surprise that we also have to combine our readings of the histories of synthetic biology, because, together, they offer rich accounts of its multiple ancestors and definitions and the many characterizations of the field. genopole.fr/Education). This "new brand" of researcher is able to do interdisciplinary work in these new fields but is also proficient in other domains (e.g., project planning, writing, thinking about economic and ethical issues). After 2008, the development of synthetic biology intensified in France. Conferences and debates on the theme of synthetic biology began to be organized, and a pôle de recherche (research consortium) on the theme of synthetic and systems biology was launched at the Pôle de Recherche et Enseignement Supérieur UniverSud (PRES), a research cluster involving various universities in the south of Paris (the overall funding of PRES decreased in 2010, however, so that thematic pôles were discontinued, including the one on synthetic biology).
In 2010, the Institute of Systems and Synthetic Biology was created in Évry. This institute was built as a result of the joint efforts of Genopole (the main player in the field of genomics research in France), the French National Center for Scientific Research, and the University of Évry Val d'Essonne, but even before the institute was actually established, the French agency for evaluating research and higher education evaluated it, highlighting its national and international acclaim; its good relationships with socio economic actors; its motivated and productive staff; but also its lack of a long-term vision, of a common theme, and of scientific leadership (AERES 2009 ). The Institute of Systems and Synthetic Biology is today an inter disciplinary group of 40 scientists, including chemists, physicists, and computational and molecular biologists. Its research activities-aiming to "develop models and experimental methods for studying the structure, architecture, expression, and evolution of genomes… [and] to design, build, and test new biological Biology in History circuits and devices" (www.issb.genopole.fr/Research)-are carried out by five research teams, of which four work in the field of synthetic biology.
We see, then, that in France, synthetic biology developed on a bottom-up and sometimes even student-driven basis and also developed laterally, influenced by US initiatives. The lack of top-down dynamics is noteworthy, since, at least until very recently, the French government did not have a dedicated policy in the field. The need to foster a community of synthetic biologists was also seen as an important goal right from the start. In its early days, synthetic biology emerged as a set of joint efforts that were aimed at establishing a discipline in terms of institutions, education, networks, and a community and an identity for the field. But it took another year for the government to embark on a more substantial characterization of the field. The SNRI created a working group on synthetic biology in 2010, with the mission to assess the developments, potential, and challenges of synthetic biology. The report of the group was eventually published in March 2011, with a list of five key factors for its success: "(1) Concentrate the talents in the hard sciences, humanities, social sciences, and engineering around [synthetic biology]; (2) forge a strong identity with a European scope, and propose a regulatory framework; (3) create international interest and visibility; (4) synergize training, research, platform, development, [and] industry; [and] (5) encourage a transparent societal dialogue, [and] involve society in programming" (SNRI 2011, p. 13) .
The report further recommended, among other things, the establishment of a national forum on synthetic biology, a financial policy to encourage research, spaces for dialogues with the public, the creation of platforms to bring together public and private actors, and the "responsibilization" of researchers.
But before the report was released, the French Parliamentary Office for the Evaluation of Scientific and Technological Choices (OPECST) embarked on a wide review of the field. The OPECST carried out 160 interviews with synthetic biology actors in France and abroad and reviewed some of the key literature in the field in order "to establish a worldwide state of the art and the position of our country in terms of training, research, and technology transfer" (Fioraso 2012a) .
The report, titled The Challenges of Synthetic Biology (Fioraso 2012b) , was finally published in February 2012 and was aimed at providing an assessment of the main ethical, legal, economic, and social challenges of the field. The report contains a list of several recommendations for a "controlled" and "transparent" development of synthetic biology. This wording is not surprising, given that the development of genetically modified organisms in France has been regularly criticized for a lack of transparency and given that the government prefers to avoid such controversy. Indeed, the French government seems more cautious today: Before actually supporting the science itself, efforts are made to assess potential dangers, ethical concerns, and public opinion and to reassure the public that scientific developments are now under control and will be transparent. One of the recommendations made was to "set up a complete and integrated field. Support the establishment of a real field, ranging from basic research to industrial applications, through training, joint research, valuation, start-ups, up to pilot production lines for industry" (Fioraso 2012b, p. 193) . There are a number of synergies between the SNRI and the OPECST report: Both were written by a group of people headed by Képès, they make similar recommendations and conclusions, and both are quite optimistic about the potential of the field. The key difference between the reports is foremost a quantitative one: The latter is more explicit, more detailed, and longer (225 pages) than the former (24 pages).
It is worth contrasting the French policy with those of the United Kingdom, the United States, and the European Union (see Zhang and colleagues [2011] The governance of synthetic biology became an official matter only after 2011. There is also currently no funding stream available for synthetic biology in France (Képès 2012 , Pei et al. 2012 . Although both the SNRI and the OPECST report made recommendations for future developmentsincluding setting up funding policies and platforms-it remains to be seen when and where investments will be made and whether dedicated financial and institutional support will be available.
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The issues highlighted in France's reports on synthetic biology resemble those articulated in other national reports in terms of developments and ethical, legal, and social issues. Particular terms, such as responsible innovation, have also been imported from those previous reports. Over the past few years, the European Commission has devoted several reports to responsible innovation in the sciences (e.g., nanotechnology, information and communication technologies, life sciences, biotechnology) and its Science in Society work program for 2014-2020 also contains a responsible research and innovation component. Besides the drive through policymakers, we have also witnessed an institutionalization within the academic world, through the creation of chairs, observatoires, courses, and conferences dedicated to responsible innovation, as well as an increasing number of publications on the analysis of that concept (e.g., Hellström 2003 , Rip 2005 , Owen and Goldberg 2010 .
In at least one respect, however, France presents a difference from other countries: the way in which it approaches the dialogue between science and society and, especially, the fact that it has established the Observatoire for Synthetic Biology-which, to date, is the first institution of its kind in the world.
Debating synthetic biology
The necessity to organize a dialogue between science and society has been highlighted by the two aforementioned reports: the SNRI recommends a real and transparent dialogue between science and society, and the OPECST report calls for a serene, peaceful, and constructive public discussion. The OPECST and the Institut Francilien Recherche Innovation Société (IFRIS; see below) reports devote several pages to the public dialogue on synthetic biology held in the United Kingdom in 2009 and 2010, providing a detailed description of its process and organization and even calling it the most "complete" dialogue of its kind (Fioraso 2012b, p. 176) . The UK dialogue is clearly the main reference point for France, whereas other initiatives, such as those in the Netherlands, in Germany, and in the United States, are only very briefly mentioned. In fact, the need for a public discussion on synthetic biology has to be placed in its wider and historic context: the drive to avoid controversies such as those around genetically modified organisms; an increasing emphasis on dialogue and public debate and participation in Europe since the 1990s (Marris and Rose 2010); French experiences in debating nanotechnology; and, in general, the belief that emerging sciences need to be opened up to early, democratic, and pluralistic assessments.
In order to outline the contours of this dialogue, the French Ministry of Higher Education and Research commissioned a report in 2011 by IFRIS (Joly et al. 2011) . The recommendations were to follow three steps: the establishment of an observatoire, the creation of a permanent forum for discussion, and the enlargement of the debate to include lay citizens.
Following this report, in January 2012, the Observatoire de la Biologie de Synthèse (Observatoire for Synthetic Biology) was set up at the French National Conservatory of Arts and Crafts (CNAM), a higher-education institution funded by the French government and dedicated to education and research and the dissemination of scientific and technical culture. The Observatoire was created at the CNAM for essentially two reasons: The CNAM is seen as a privileged and neutral place, and it already has experience in sciencesociety dialogues through NanoForum, a public forum on nanotechnology. The Observatoire is coordinated by an intentionally pluralistic council that is designed to reflect the different stakeholders and positions of the field. In general terms, the Observatoire for Synthetic Biology aims to "be the nodal point for the circulation of information, reflections, discussions about synthetic biology" and to be a "place of experimentation… for a science-society dialogue" (http:// biologie-synthese.cnam.fr). Its roles are to collect information, to mobilize actors, to follow debates, to analyze the various positions, to reflect, and to manage a public Web site. A public forum, called Forum de la Biologie de Synthèse and consisting of 9 two-hour public debates, is to be organized in 2013 and 2014.
But this Observatoire is neither the only nor the first place where debates about synthetic biology are-or will be-happening. Two associations, VivAgora and the Fondation Sciences Citoyennes, have been interested in the field of synthetic biology since 2008. VivAgora, among other activities, has called for the establishment of a permanent bioforum and has repeatedly argued that debates should not be focused solely on the issue of risk but also on social and ethical issues and on the fabrication of life (the role of civil society organizations in promoting and shaping public debates and emphasizing societal issues in synthetic bio logy was analyzed by Stemerding and colleagues [2010] ). In 2009, the association organized a series of debates on synthetic biology, and in 2011, two of its members published a comprehensive and comprehensible book on the field (Bensaude-Vincent and Benoit-Browaeys 2011). One of the cofounders of VivAgora criticized the idea of the Observatoire for Synthetic Biology, stressing that the dialogue should be focused not only on the construction of certain issues but also on agreements and disagreements, and he kept the Observatoire from adopting an "analytically and academically overhanging posture, welcoming the positions of each other but without being able to make them appear as the driving force of the debate" (Perrier 2012 ). This "overhanging posture"-that is, an academic position that is somewhat above the debates-would therefore run the risk of sidelining public or lay discourse.
One of the first activities of the Observatoire is to map the actors, activities, and challenges in the field of synthetic biology. The Web site of the Observatoire (http://biologiesynthese.cnam.fr) was launched in fall of 2012 and, interestingly, in order to reach its goal of transparency, the charter of deontology of the Observatoire will be accessible on the
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Web site, and members of the council of orientation have been asked to declare their interests.
The Observatoire for Synthetic Biology is perhaps best understood as an assemblage of various elements: the CNAM; particular models of participation, such as citizen conferences and NanoForum, both of which will have be adapted to synthetic biology; a given set of expertise (e.g., through the various members of its board and the different texts available on the Observatoire's Web site); and its publics, which are yet to be constituted. It will be of academic interest to examine how future debates will be defined, organized, and framed and what kinds of questions will be asked. An essential aspect will be to trace the effects and consequences of the Observatoire on science policy and on science. How will the Observatoire encourage society to be "involved in the programming" of synthetic biology, as was recommended by the SNRI report (SNRI 2011, pp. 3, 16) ? Will the Observatoire have a direct input into policymaking and a tangible influence on scientists' practices? Or is it bound to have, perhaps, an undesired side effect-namely, the risk of giving those scientists and policymakers not directly involved in the Observatoire the impression that they themselves do not need to engage in dialogues, since that will be seen as being in the purview of the Observatoire? Besides adopting an academic posture above the debates, the Observatoire might perhaps risk being in a loosely coupled or tangential posture-that is, a place where actors converse about science but do not really engage with science.
Debates about synthetic biology will probably not be limited to any single institution or event. Other places and formats for debating about and engaging with synthetic biology exist and might come to play a certain role in the future: engagements through art that deals with synthetic biology, the establishment of do-it-yourself biology, or controversies reported and amplified in the media. Do-ityourself biology, for instance, has emerged in France, and an association named La Paillasse has been reflecting on the legal, democratic, and political issues of practicing biology in noninstitutional settings (Meyer 2012a (Meyer , 2012b .
Positioning French synthetic biology "France has strong competences, but which are too diffuse, with too strong disciplinary boundaries in training and research. In fact, one can be concerned that without a proactive science policy, France, in spite of all the assets needed to develop [synthetic biology], which it does possess, risks missing the bioeconomy train" (Fioraso 2012b, p. 203) .
Quotes such as this are interesting for several reasons. First, the claim is that France is indeed "strong" and that the country should remain so. A dedicated science policy and the restructuring of the current research landscape are portrayed as the solution to make sure that France remains a country engaged in significant and up-to-date research. Second, the idea of being "too late" is noteworthy. Such an argument is, of course, not particular to synthetic biology or to France, but it does reveal that not only does France wish to embark on synthetic biology per se, but it also wants to position itself more globally (with the United States, the United Kingdom, Europe, and Germany being the main reference points for comparison). France's position was made most explicit in the SNRI report, in which it was written that France could "aim for a world position of second or third" (SNRI 2011, p. 2) .
Such expectations are a prominent feature in science. Academic work has analyzed such sociotechnical narratives (Felt et al. 2007) or "imaginaries" (Jasanoff 2005) and how the future of science is something constructed but also contested (Brown et al. 2000, Brown and Michael 2003) . In particular, it is now common to argue that expectations are performed and that there is not one predetermined future; rather, it is argued that futures are plural and that they are technically as well as socially and politically constructed. France's official discourse is no exception here, and the rather optimistic way in which it constructs the future of synthetic biology is noteworthy: Words such as new, potential, advances, impact, and feasibility abound, and new kinds of products, applications, benefits, and markets have been promised (in the OPECST and SNRI reports, but also elsewhere).
Besides the international positioning of French synthetic biology, current debates are also concerned with the positioning and structuring of synthetic biology on a national level. Some have argued that the field is "not yet structured," that it is important to "constitute a real interdisciplinary community covering the whole of the academic and industrial territory," and that the "community must constitute itself from the ground [up] but with effective and declared support… from the top" (ITMO 2011, pp. 86, 88) . In terms of future development, both the SNRI and the OPECST report recommend the establishment of platforms. The SNRI recommends between two and four platforms, and the OPECST report recommends what it calls "locomotive platforms" in five locations: Paris-Ile de France (Évry), Toulouse, Bordeaux, Grenoble, and Strasbourg. To date, however, synthetic biology is concentrated in a small number of regions; most researchers working in the field are today at Genopole, in Évry (Képès 2010) , and a number of research activities have emerged in cities such as Toulouse, Strasbourg, and Lyon.
Although the private sector in France is active in the domains of biofuels and chemistry, public-private partnerships are generally quite poor in France compared with those in the United States and Germany (Fioraso 2012b) . Therefore, one of the ideas behind the proposed platforms is to bring together public and private actors. Platforms are, in general, created in order to share (increasingly costly and sophisticated) instruments among labs or institutions and to gather a critical mass of researchers in one place. They are imagined as a way to improve the organizational and communication facets of science, because they are intended to reconfigure scientific collectives, to make science more visible or recognizable, to become a symbol
biology as an (inter)discipline, we are also witnessing a politicization and publicization of the field. These moves also bring about different ways of thinking about science. In Foucauldian terms, apart from the construction of synthetic biology as an object, we also see the making of synthetic biology as a problem and a set of questions (Foucault 1984) . Although we observe efforts to assemble synthetic biology as an (inter)discipline within scientific institutions, we also see efforts to converse, observe, and reflect about the practices and objects of synthetic biology-in other words, to problematize synthetic biology. The ways in which all of these objectifications, politicizations, problematizations, and publicizations of synthetic biology interact with, influence, and coproduce one another are a fruitful topic for further analyses.
An idea developed by biologist Antoine Danchin can help us further theorize these kinds of interactions. Danchin coined the concept of symplectic biology, a kind of biology that weaves together objects and disciplines. In his words, "under this scheme, the roadmap to engineering biological systems is determined not by the biological parts but rather by how they interact.… The relationships between the objects-and not necessarily the objects themselvesare crucial to any attempt to construct a synthetic cell with nonnatural properties" (de Lorenzo and Danchin 2008, pp. 825-826) . Such a "symplectic" vision-which we might also call relational or integrative-can be productive for thinking about synthetic biology. Besides referring to relations between objects, the notion could be generalized and broadened to include the politics and the publics concerned with those objects. This could, then, serve as a potent reminder that synthetic biology should not and cannot be discussed in isolation. On the contrary, synthetic biology needs to be conceived in an integrated way, as an assemblage of scientific objects, policies, problems, and publics.
As much as natural scientists should not reduce their vision of synthetic biology to objects alone, social scientists should not reduce their analysis to categories such as social, legal, or ethical as if the socioeconomic, political, and moral dimensions of synthetic biology could be broken down into such neat parts. What social scientists can offer, instead, are relational accounts on how the history, governance, geopolitics, and debates of synthetic biology are woven together and why synthetic life needs to be discussed together with social life. and a communication tool to valorize science, and to play a double role-in the creation of new knowledge and in the transfer of technology to industrial partners (Aggeri et al. 2007 , Hubert 2011 . The strategies to construct such platforms therefore generally entail similar goals, such as formulating scientific expectations and promises: recruiting actors, attracting investment, and building scientific and political legitimacy, but also justifying institutional and national restructurings.
Apart from Évry, a city that already hosts research and industry actors, there is another project that needs to be mentioned: Toulouse White Biotechnology was launched in 2011 and was granted 20 million in funding. Toulouse White Biotechnology is working in several areas-synthetic biology, enzyme and metabolic engineering, the production of biomolecules-and has three main missions: to foster the emergence of an economy based on the use of renewable carbon; to catalyze scientific innovation; and to stimulate links between basic, applied, and industrial research. The goals of Toulouse White Biotechnology are to become a "future centre of excellence" (www.toulouse-whitebiotechnology.com/TWB) and a "laboratory of reference" (www.toulouse-white-biotechnology.com/Formation/ Ecoledoctorale) in the field of synthetic biology.
The role of the social sciences The way in which science, policy, and the public interact is and will continue to be a fascinating topic that social scientists should not overlook. In fact, in some countries, the social sciences have been closely involved in synthetic biology: For instance, the US Synthetic Biology Engineering Research Center was headed by a natural scientist and an anthropologist until 2010, and in the United Kingdom, social scientists cocreated seven networks in synthetic biology funded from 2008 to 2011 (Molyneux-Hodgson and Meyer 2009, Rabinow and Bennett 2009 ). Calvert and Martin (2009) proposed a distinction between social scientists' role as contributors, experts "plugged in" after natural scientists have produced scientific knowledge, and that as collaborators, who can actually influence and interact with knowledge production. In addition to these, other types of involvement can be imagined for social scientists: accomplices, who uncritically buy into natural scientists' rationales and visions; critics, who are critical of the science but run the risk of being excluded from it; or analysts, who provide academic analyses but without direct involvement in policymaking or science. In contrast to the situation in the United States and the United Kingdom, in countries such as France, the Netherlands, and Switzerland, the social sciences have played a more or less marginal role in synthetic biology so far (Pei et al. 2012) .
In France, synthetic biology has, for a few years, gradually emerged as a practice and a community. Over the past 3 years, it has become an issue for policymakers, and synthetic biology is soon due to become a public topic as well. In other words, besides the establishment of synthetic
